The purpose of this report is to enrich the information and knowledge base of harm reduction interventions in Europe from the viewpoint of civil society organisations. We believe that this approach is a necessary, and useful, contribution to the development of drug policy in the region (Correlation Harm Reduction Network, The Netherlands)
Bibliography: Interventions – Harm Reduction
Medication Assisted Treatment
MAT Standards for Scotland (Scottish Drugs Death Taskforce)
Drug control policies in Eastern Europe and Central Asia
The economic, health and social impact (Economist Intelligence Unit)
A state policy option to expanding access to methadone: Utilize Federally Qualified Health Centers
A state policy option to expanding access to methadone: Utilize Federally Qualified Health Centers (Recovery Research Institute)
Doing more harm than good
International examples of success, growing public support and the clear failure of current laws to stop drug use means the time is right now for drug law reform (Australian Lawyers Alliance)
Syringe Distribution Programs Can Improve Public Health During the Opioid Overdose Crisis
Such initiatives can reduce overdose rates and infectious disease, increase use of treatment (PEW)
College publishes report on drug-related deaths in Scotland
The Royal College of Physicians of Edinburgh (“the College”) has launched a new report on drug-related deaths in Scotland, based on the views of leading experts
Key findings from the ‘Australians’ Drug Use: Adapting to Pandemic Threats’ (ADAPT) Study Wave 3
The Australians’ Drug Use: Adapting to Pandemic Threats (ADAPT) Study is exploring the short and long-term impact of the COVID-19 pandemic on the experiences of Australians who use illicit drugs (NDARC)
Maximising access to drug treatment while minimising diversion of medications
A new EMCDDA report looks at striking the balance
Understanding high death rates of people with multiple and complex needs
Many people experiencing homelessness, drug and alcohol problems, mental ill health, and repeat offending die early as they become desensitised to death through suffering vast loss and lack of hope, new research has revealed (Fuse, the Centre for Translational Research in Public Health)
Government of Canada supports four safer drug supply projects in British Columbia
Life-saving initiatives will provide pharmaceutical-grade medication as alternative to toxic illegal drug supply during COVID-19 outbreak and beyond (Government of Canada)
ICER Publishes Final Evidence Report and Policy Recommendations for Supervised Injection Facilities
The Institute for Clinical and Economic Review (ICER) today released a Final Evidence Report and Report-at-a-Glance assessing the comparative clinical effectiveness and value of supervised injection facilities (SIFs), as a means to reduce harm among people who inject drugs
A Supplemental Report on British Columbia’s Unregulated Drug Supply Amidst Dual Public Health Emergencies
Results from British Columbia’s Community Drug Checking Service January 2020 – October 2020
Assessment of the harms of gamma-hydroxybutyric acid, gamma-butyrolactone, and closely related compounds
This report provides an updated harms assessment of gamma-hydroxybutyric acid (GHB) and related substances (ACMD)
Supervised Injection Facilities and Other Supervised Consumption Sites: Effectiveness and Value
The purpose of this assessment is to evaluate the health and economic outcomes of a Supervised Injection Facility. This review seeks to answer the question: What is the net health benefit of implementing a SIF (which includes an SSP) versus an SSP alone? (ICER)
Key findings from the ‘Australians’ Drug Use: Adapting to Pandemic Threats’ (ADAPT) Study Wave 2
The Australians’ Drug Use: Adapting to Pandemic Threats (ADAPT) Study is exploring the short and long-term impact of the COVID-19 pandemic on the experiences of Australians who use illicit drugs (NDARC)
Preliminary patterns in circumstances surrounding opioid-related deaths in Ontario during the COVID-19 pandemic
This report describes the preliminary patterns in circumstances surrounding opioid-related deaths in Ontario during COVID-19. An understanding of these circumstances is urgently needed to inform interventions and policies to prevent further opioid-related mortality in the midst of this pandemic (The Ontario drug policy research network)
Prevention and Treatment of HIV Among People Living with Substance Use and/or Mental Disorders
This guide reviews effective programs and practices to prevent HIV and increase adherence to and retention in care (SAMHSA)
The Global State of Harm Reduction 2020
The Global State of Harm Reduction is the only report that provides an independent analysis of harm reduction in the world (Harm Reduction International)
How to use the ASSIST-Lite screening tool to identify alcohol and drug use and tobacco smoking
Health and social care professionals are well placed to provide interventions targeted at all substances. This tool will help you to identify risky drug and alcohol use and tobacco smoking, and respond in an evidence-based way. This will contribute to reducing premature mortality and morbidity (PHE)
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- …
- 24
- Next Page »
